SETD2 and nonpapillary renal cell carcinoma: Histone methyltransferase SET-domain-containing 2 (SETD2) is one of the most frequently mutated genes in ccRCC and plays major roles in epigenetic regulation of functional pathways in the development and progression of ccRCC9–11.